Searches , social queries for INSULIN GLARGINE
Search references for INSULIN GLARGINE. Phrases containing INSULIN GLARGINE
See searches and references containing INSULIN GLARGINE!
Search references for INSULIN GLARGINE. Phrases containing INSULIN GLARGINE
See searches and references containing INSULIN GLARGINE!INSULIN GLARGINE
Long-acting insulin
Insulin glargine sold, among others, under the brand name Lantus (manufactured and marketed by Sanofi) is a long-acting modified form of medical insulin
Insulin_glargine
Combination drug
Insulin glargine/lixisenatide, sold under the brand name Soliqua among others, is a fixed-dose combination medication that combines insulin glargine and
Insulin_glargine/lixisenatide
Ultralong-acting basal insulin analogue
long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin, that is one that provides a base insulin level, as
Insulin_degludec
Modified forms of synthetic insulin
the natural insulin response after meals. Long-acting (basal) insulin analogues, including insulin glargine, insulin detemir, and insulin degludec, provide
Insulin_analogue
Intermediate acting insulin formulation
NPH insulin to other insulin analogues (insulin detemir, insulin glargine, insulin degludec) in both children and adults with Type 1 diabetes. Insulin detemir
NPH_insulin
Drugs that lower blood glucose levels to treat diabetes
long-acting insulin preparations. As a systematic review of studies comparing insulin detemir, insulin glargine, insulin degludec and NPH insulin did not
Diabetes_medication
Use of insulin protein and analogs as medical treatment
regular insulin), intermediate-acting (such as neutral protamine Hagedorn (NPH) insulin), and longer-acting (such as insulin glargine). Insulin is used
Insulin_(medication)
Peptide hormone
for human insulin and animal insulins. The other type is long acting insulin; the first of these was Lantus (insulin glargine). These have a steady effect
Insulin
Ultralong-acting basal insulin analogue
development as a once-weekly basal insulin. In ONWARDS 1, once-weekly insulin icodec was compared with once-daily insulin glargine U100 in adults with type 2
Insulin_icodec
Indian multinational biopharmaceutical company
products. Some of Biocon's key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin)
Biocon
Medication
number NCT05462756 for "A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type
Insulin_efsitora_alfa
Anti-diabetic and anti-obesity medication
tirzepatide was superior to dulaglutide, semaglutide, insulin degludec, and insulin glargine in improving blood sugar control and reducing body weight. In a phase
Tirzepatide
biosimilar insulin product, Semglee (insulin glargine-yfgn), for the treatment of diabetes. Unbranded versions of insulin glargine and insulin glargine-yfgn
List of commercially available insulins
List_of_commercially_available_insulins
Chemical compound
established. GLP-1 receptors improve insulin sensitivity and increase satiety. Retatrutide has shown to increase insulin secretion. Furthermore, agonism of
Retatrutide
Long-acting man-made insulin
review also compared the effects of insulin detemir to NPH insulin and other insulin analogues (insulin glargine, insulin degludec) in both children and adults
Insulin_detemir
French multinational pharmaceutical and healthcare company
(Human insulin), for type 1 and type 2 diabetes mellitus. Lantus (insulin glargine), for type 1 and type 2 diabetes mellitus. Soliqua (insulin glargine/lixisenatide)
Sanofi
Form of diabetes mellitus
controlled). When nightly insulin is insufficient, twice daily insulin may achieve better control. The long acting insulins glargine and detemir are equally
Type_2_diabetes
Gastrointestinal peptide hormone involved in glucose homeostasis
sugar levels in a glucose-dependent manner by enhancing the secretion of insulin. Beside the insulinotropic effects, GLP-1 has been associated with numerous
Glucagon-like_peptide-1
Anti-diabetic and anti-obesity medication
Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Semaglutide
Pharmaceutical drug classification
(human) A10AE02 Insulin (beef) A10AE03 Insulin (pork) A10AE04 Insulin glargine A10AE05 Insulin detemir A10AE06 Insulin degludec A10AE07 Insulin icodec A10AE30
ATC_code_A10
American pharmaceutical company
medication), Humalog (insulin lispro), and the first approved biosimilar insulin product in the US, Basaglar (insulin glargine). It achieved commercial
Eli_Lilly_and_Company
Medication used to treat diabetes
It works by decreasing glucose production in the liver, increasing the insulin sensitivity of body tissues, and increasing GDF15 secretion, which reduces
Metformin
Anti-obesity medication
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Orforglipron
Medication
showed a HbA1c reduction of 0.20% more with exenatide 2 mg compared to insulin glargine, exenatide 10 μg twice daily, sitagliptin and pioglitazone. Exenatide
Exenatide
Rapid-acting insuline analog
Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. It is
Insulin_lispro
Chronic disease of cats
Diabetic cats do best with long-lasting twice-daily injections of insulin such as glargine (which as of 2022 is available worldwide as a synthetic generic
Diabetes_in_cats
Chemical compound
treat type 2 diabetes. It may be used with metformin, a sulfonylurea, or insulin. Use is recommended together with exercise and diet. It is not recommended
Pioglitazone
Diabetes medication
peptidase-4 (DPP-4) inhibitor class and works by increasing the production of insulin and decreasing the production of glucagon by the pancreas. In the United
Sitagliptin
Variant of a biopharmaceutical
lambda, etanercept, filgrastim, follitropin alfa, infliximab, insulin aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab. Biosimilar
Biosimilar
Short-acting insulin formulation
Regular insulin, also known as neutral insulin and soluble insulin, is a type of short-acting medical insulin. It is used to treat type 1 diabetes, type
Regular_insulin
Diabetes medication
be assessed. Dapagliflozin can cause low blood sugar when combined with insulin. To lessen the risk of developing ketoacidosis after surgery, the US FDA
Dapagliflozin
Chemical compound
It works by stimulating the pancreas to release insulin and increases tissue sensitivity to insulin. Glipizide was approved for medical use in the United
Glipizide
Project to develop an open source protocol for producing insulin
methods for insulin production available for anyone to use. The project has genetically engineered microorganisms to produce long-acting (glargine) and short-acting
Open_Insulin_Project
Pharmaceutical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Brenipatide
Historical formulation of insulin as medication
favor with doctors in the mid-2000s, when insulin analogues such as glargine began to be approved. Insulin analogues made by recombinant DNA production
Lente_insulin
Chemical compound
sulfonylurea family of medications. It works mostly by increasing the release of insulin. Gliclazide was patented in 1966 and approved for medical use in 1972.
Gliclazide
Diabetes medication
aiding the pancreas to release the correct amount of insulin when blood sugar levels are high. Insulin helps to move sugar from the blood onto other body
Dulaglutide
Class of organic compounds used in medicine and agriculture
are medically used in the management of type 2 diabetes by stimulating insulin secretion. Sulfonylureas are the most widely used herbicide. Many sulfonylureas
Sulfonylurea
Chemical compound
and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the
Vildagliptin
Long-acting medication preparation
and middle income countries. Insulin may also be considered a depot injection depending on formulation. Insulin glargine, for example, is designed to
Depot_injection
Drug storage and delivery device
liraglutide and insulin glargine with lixisenatide. Combination products are available in fixed-dose ratios and are generally dosed by units of insulin, which
Injector_pen
Class of chemical compounds
protein, this causes upregulation of genes (for a full list see PPARγ): Insulin resistance is decreased Adipocyte differentiation is modified VEGF-induced
Thiazolidinedione
Peptide drug
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Survodutide
Anti-diabetic medication
HbA1c reduction of 0.24% more with liraglutide 1.8 mg compared to insulin glargine, 0.33% more than exenatide 10 μg twice daily, sitagliptin and rosiglitazone
Liraglutide
Chemical compound
if diet alone is not effective. Tolbutamide stimulates the secretion of insulin by the pancreas. It is not routinely used due to a higher incidence of
Tolbutamide
Diabetes medication
weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately
Empagliflozin
Chemical compound
2 diabetes. The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs
Repaglinide
Powdered insulin delivered with an inhaler
Inhalable insulin is a powdered form of insulin, delivered with an inhaler into the lungs where it is absorbed. In general, inhaled insulins have been
Inhalable_insulin
Chemical compound
fasting plasma glucose and HBA1c in diabetes patients. Saroglitazar is an insulin sensitizer. It is a first in class drug which acts as a dual PPAR agonist
Saroglitazar
Chemical compound
other sulfonylureas, chlorpropamide acts to increase the secretion of insulin, so it is only effective in patients who have some pancreatic beta cell
Chlorpropamide
Combination medication
Insulin degludec/insulin aspart, sold under the brand name Ryzodeg, is a fixed-dose combination medication for the treatment of diabetes mellitus. It contains
Insulin degludec/insulin aspart
Insulin_degludec/insulin_aspart
Diabetes drug
offer two pens with different ratios of insulin glargine and lixisenatide - one for people who had never taken insulin before and one for people who had; there
Lixisenatide
Pharmaceutical drug
Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes
Insulin_degludec/liraglutide
Chemical compound
sulfonylureas class of medications and works by increasing the release of insulin from the pancreas. Glibenclamide was discovered in 1969 and approved for
Glibenclamide
American rapper (born 1982)
2020, he took to Instagram to ask the public for help in locating insulin glargine, also known as Lantus, asking followers in the Jacksonville area to
Boosie_Badazz
GLP1 poly-agonist drug
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Mazdutide
Rapid-acting man-made insulin
Insulin aspart, sold under the brand name Novolog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. It is
Insulin_aspart
Chemical compound
in conjunction with insulin therapy.[citation needed] Mainly used in Type II diabetes, metformin is considered to increase insulin sensitivity in vivo
Biguanide
Chemical compound
USA'S Food & Drug Administration not approving sotagliflozin along with insulin for the emergency treatment of hyperglycemia. Similar concerns led to the
Sotagliflozin
Anti-diabetic drug
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Alogliptin
Chemical compound
trials of weekly taspoglutide (four against exenatide, sitagliptin, insulin glargine, and pioglitazone), at least five were active in 2009. Preliminary
Taspoglutide
Medication
diabetes; its mode of action is to increase insulin secretion by the pancreas. However it requires adequate insulin synthesis as prerequisite to treat appropriately
Glimepiride
Oral anti-diabetic drugs
Helen (2017). "Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double-blind
Alpha-glucosidase_inhibitor
Therapeutic regimen for diabetes mellitus treatment
standard of basal insulin. Long-acting insulin analogs such as insulin glargine (brand name Lantus, made by Sanofi-Aventis) and insulin detemir (brand name
Intensive_insulin_therapy
Chemical compound
dipeptidyl peptidase-4 inhibitor that works by increasing the production of insulin and decreasing the production of glucagon by the pancreas. It is generally
Linagliptin
Class of drugs used to treat diabetes
incretin effect of GIP and GLP-1 accounts for around 50–70% of post-meal insulin secretion. This effect is substantially reduced in people with type 2 diabetes
GLP1_poly-agonist_peptides
Drug used for the treatment of symptoms of metabolic syndrome
thiazolidinediones (TZDs), used in diabetes mellitus and other diseases that feature insulin resistance. It is also mildly activated by certain NSAIDs (such as ibuprofen)
PPAR_agonist
Chemical compound
by people without any toxic effects. Combining ertugliflozin with insulin or insulin secretagogues (such as sulfonylureas) may result in an increased risk
Ertugliflozin
Scientific branch of chemistry
fluticasone, clopidogrel) and "biologics" (infliximab, erythropoietin, insulin glargine), the latter of which are most often medicinal preparations of proteins
Medicinal_chemistry
Rapid-acting insulin analogue
Insulin glulisine, sold under the brand name Apidra among others, is a rapid-acting modified form of medical insulin used for the treatment of diabetes
Insulin_glulisine
Formulary by the World Health Organization
alternative Insulin glargine, Insulin degludec, and insulin detemir, including quality-assured biosimilars, are alternatives Insulin lispro, Insulin aspart
WHO Model List of Essential Medicines
WHO_Model_List_of_Essential_Medicines
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Enavogliflozin
Pharmaceutical drug
agonist; and as add-on to insulin as an adjunct to diet and exercise to improve glycemic control in people when stable dosage of insulin and metformin alone
Sitagliptin/metformin
Chemical compound
resulting calcium influx induces fusion of insulin-containing vesicles with the cell membrane, and insulin secretion occurs. Nateglinide is contraindicated
Nateglinide
Pharmaceutical compound
Insulin tregopil is a fast-acting insulin analog which, unlike other forms of insulin, is delivered by mouth. It is developed by Biocon for diabetes.
Insulin_tregopil
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Lotiglipron
Medication
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Dapagliflozin/sitagliptin
American biologist
(January 2015). "Enhancement in production of recombinant two-chain Insulin Glargine by over-expression of Kex2 protease in Pichia pastoris" (PDF). Applied
Charles_Brenner_(biochemist)
Chemical compound
conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required Pregnancy or breastfeeding Gliquidone is fully
Gliquidone
Chemical compound
class. It works as an insulin sensitizer, by binding to the PPAR in fat cells and making the cells more responsive to insulin. It is marketed by the
Rosiglitazone
Chemical compound
responsible for the beneficial actions of saxagliptin, including increasing insulin production in response to meals and decreasing the rate of gluconeogenesis
Saxagliptin
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Acarbose
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Ipragliflozin
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Danuglipron
Pharmaceutical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Conveglipron
Combination drug
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Glibenclamide/metformin
Medication
as reconstituted glucagon in reversing severe hypoglycemia induced by insulin, with a median recovery time of 10 minutes compared to 12 minutes for reconstituted
Dasiglucagon
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Carbutamide
Chemical compound
delays absorption of glucose from the gastrointestinal tract, increases insulin sensitivity and glucose uptake into cells, and inhibits synthesis of glucose
Buformin
Class of medication
gliflozins cause less stimulation of endogenous insulin secretion or lower dose of exogenous insulin that results in diabetic ketoacidosis. They can specifically
SGLT2_inhibitor
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Metahexamide
Combination drug
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Empagliflozin/linagliptin/metformin
Empagliflozin/linagliptin/metformin
Chemical compound
hypoglycemia associated with insulin and earlier oral antidiabetic drugs. It was further believed that reducing insulin resistance would potentially reduce
Troglitazone
Enzyme blocker and diabetes treatment drug
(GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying, and decreases blood glucose levels
Dipeptidyl peptidase-4 inhibitor
Dipeptidyl_peptidase-4_inhibitor
Dopamine agonist medication
as decreases in blood glucose levels, hepatic glucose production, and insulin resistance. It therefore acts as an adjunct to diet and exercise to improve
Bromocriptine
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Retagliptin
Formulary
salts Insulin glargine, Insulin degludec, and insulin detemir, including quality-assured biosimilars, are alternatives Insulin lispro, Insulin aspart
WHO Model List of Essential Medicines for Children
WHO_Model_List_of_Essential_Medicines_for_Children
Indian medical doctor
al. Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with
Sanjay_Kalra
Diabetes medication
the bloodstream by the β cells of the pancreas along with insulin after a meal. Like insulin, amylin is completely absent in individuals with Type I diabetes
Pramlintide
Chemical compound
glulisine Insulin lispro Short-acting Regular insulin# Long-acting Insulin detemir# Insulin glargine# (+lixisenatide) NPH insulin Lente insulin‡ Ultralente
Tolazamide
travel, tourism, insurance
INSULIN GLARGINE
INSULIN GLARGINE
Surname or Lastname
English
English : topographic name from Anglo-Norman French del isle ‘of the island’, or a habitational name from the common French place names Lisle or Lille, all derived from Old French isle (Latin insula) ‘island’.French : habitational name from the city of Lille, Nord (see 1).
Male
English
Old English name derived from the element hux, HUCC means "insult, taunt." Possibly a byname before becoming a personal name.
Surname or Lastname
English (mainly Somerset and Gloucestershire)
English (mainly Somerset and Gloucestershire) : topographic name from Anglo-Norman French isle ‘island’ (Latin insula) or a habitational name from a place in England or northern France named with this element.
Surname or Lastname
English (mainly Shropshire)
English (mainly Shropshire) : habitational name from a place in Cheshire, which is probably so called from the genitive case of the Old English personal name Hucc or from Old English husc, hux ‘insult’, ‘taunt’ + lēah ‘wood’, ‘clearing’.
INSULIN GLARGINE
INSULIN GLARGINE
INSULIN GLARGINE
INSULIN GLARGINE
INSULIN GLARGINE
INSULIN GLARGINE
INSULIN GLARGINE
p. pr. & vb. n.
of Insult
imp. & p. p.
of Insult
n.
A substance of very wide occurrence. It is found dissolved in the sap of the roots and rhizomes of many composite and other plants, as Inula, Helianthus, Campanula, etc., and is extracted by solution as a tasteless, white, semicrystalline substance, resembling starch, with which it is isomeric. It is intermediate in nature between starch and sugar. Called also dahlin, helenin, alantin, etc.
n.
Insolent conduct or treatment; insult.
n.
A mock; an insult.
n.
One who insults.
a.
Insular.
v. t.
To treat with abuse, insolence, indignity, or contempt, by word or action; to abuse; as, to call a man a coward or a liar, or to sneer at him, is to insult him.
n.
See Inulin.
a.
Of or pertaining to an island; of the nature, or possessing the characteristics, of an island; as, an insular climate, fauna, etc.
a.
Containing, or characterized by, insult or abuse; tending to insult or affront; as, insulting language, treatment, etc.
a.
Of or pertaining to the people of an island; narrow; circumscribed; illiberal; contracted; as, insular habits, opinions, or prejudices.
adv.
With scoffing or insulting language.
n.
A variety of starch extracted from the dahlia; -- called also inulin. See Inulin.
n.
Insolent treatment; insult.
a.
Expressing reproach; insulting.
adv.
In an insular manner.
n.
The act of insulting; abusive or insolent treatment; insult.
a.
Censorious; severe in language; sarcastic; insulting.
v. t.
To insult.
travel, tourism, insurance